)
From Pilot to Implementation: Bupa’s Use of Genomics for Personalised, Preventive Care
-
Outcomes from a 16,000-person WGS global pilot for Pharmacogenomics and PRS
-
Integrating Medication Check, polygenic risk scores (PRS) and monogenic tests into clinical pathways
-
The impact of being the first UK insurer to fund preventive treatment.
